VIR logo

Vir Biotechnology, Inc. (VIR) CAPEX

annual CAPEX:

$7.30M-$14.27M(-66.16%)
December 31, 2024

Summary

  • As of today (September 17, 2025), VIR annual capital expenditures is $7.30 million, with the most recent change of -$14.27 million (-66.16%) on December 31, 2024.
  • During the last 3 years, VIR annual CAPEX has fallen by -$14.52 million (-66.54%).
  • VIR annual CAPEX is now -89.26% below its all-time high of $68.01 million, reached on December 31, 2022.

Performance

VIR CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVIRcash flow metrics

quarterly CAPEX:

$2.54M+$909.00K(+55.80%)
June 30, 2025

Summary

  • As of today (September 17, 2025), VIR quarterly capital expenditures is $2.54 million, with the most recent change of +$909.00 thousand (+55.80%) on June 30, 2025.
  • Over the past year, VIR quarterly CAPEX has increased by +$1.87 million (+281.08%).
  • VIR quarterly CAPEX is now -87.68% below its all-time high of $20.60 million, reached on June 30, 2022.

Performance

VIR quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVIRcash flow metrics

TTM CAPEX:

$8.93M+$1.87M(+26.52%)
June 30, 2025

Summary

  • As of today (September 17, 2025), VIR TTM capital expenditures is $8.93 million, with the most recent change of +$1.87 million (+26.52%) on June 30, 2025.
  • Over the past year, VIR TTM CAPEX has increased by +$1.14 million (+14.68%).
  • VIR TTM CAPEX is now -86.96% below its all-time high of $68.50 million, reached on September 30, 2022.

Performance

VIR TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVIRcash flow metrics

VIR CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-66.2%+281.1%+14.7%
3 y3 years-66.5%-87.7%-83.9%
5 y5 years-18.3%+89.0%+112.8%

VIR CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-89.3%at low-87.7%+281.1%-87.0%+38.9%
5 y5-year-89.3%+11.5%-87.7%+281.1%-87.0%+112.8%
alltimeall time-89.3%+166.3%-87.7%+281.1%-87.0%+744.0%

VIR CAPEX History

DateAnnualQuarterlyTTM
Jun 2025
-
$2.54M(+55.8%)
$8.93M(+26.5%)
Mar 2025
-
$1.63M(-32.3%)
$7.06M(-3.3%)
Dec 2024
$7.30M(-66.2%)
$2.41M(+2.2%)
$7.30M(+13.6%)
Sep 2024
-
$2.36M(+253.8%)
$6.43M(-17.4%)
Jun 2024
-
$666.00K(-64.4%)
$7.79M(-53.0%)
Mar 2024
-
$1.87M(+22.0%)
$16.58M(-23.2%)
Dec 2023
$21.57M(-68.3%)
$1.53M(-58.7%)
$21.57M(-33.9%)
Sep 2023
-
$3.71M(-60.7%)
$32.63M(-31.9%)
Jun 2023
-
$9.46M(+37.7%)
$47.91M(-18.9%)
Mar 2023
-
$6.87M(-45.5%)
$59.05M(-13.2%)
Dec 2022
$68.01M
$12.60M(-33.7%)
$68.03M(-0.7%)
Sep 2022
-
$18.99M(-7.8%)
$68.50M(+23.4%)
DateAnnualQuarterlyTTM
Jun 2022
-
$20.60M(+30.0%)
$55.51M(+50.1%)
Mar 2022
-
$15.84M(+21.2%)
$36.99M(+69.6%)
Dec 2021
$21.82M(+233.1%)
$13.07M(+117.6%)
$21.82M(+95.1%)
Sep 2021
-
$6.01M(+189.2%)
$11.18M(+68.2%)
Jun 2021
-
$2.08M(+211.4%)
$6.65M(+12.4%)
Mar 2021
-
$667.00K(-72.6%)
$5.91M(-9.7%)
Dec 2020
$6.55M(-26.7%)
$2.43M(+64.9%)
$6.55M(+15.5%)
Sep 2020
-
$1.47M(+9.8%)
$5.67M(+35.1%)
Jun 2020
-
$1.34M(+3.1%)
$4.20M(+47.1%)
Mar 2020
-
$1.30M(-16.1%)
$2.85M(+83.9%)
Dec 2019
$8.94M(+9.1%)
$1.55M(+46.7%)
$1.55M(+46.7%)
Dec 2018
$8.19M(+198.8%)
$1.06M
$1.06M
Dec 2017
$2.74M
-
-

FAQ

  • What is Vir Biotechnology, Inc. annual capital expenditures?
  • What is the all time high annual CAPEX for Vir Biotechnology, Inc.?
  • What is Vir Biotechnology, Inc. annual CAPEX year-on-year change?
  • What is Vir Biotechnology, Inc. quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Vir Biotechnology, Inc.?
  • What is Vir Biotechnology, Inc. quarterly CAPEX year-on-year change?
  • What is Vir Biotechnology, Inc. TTM capital expenditures?
  • What is the all time high TTM CAPEX for Vir Biotechnology, Inc.?
  • What is Vir Biotechnology, Inc. TTM CAPEX year-on-year change?

What is Vir Biotechnology, Inc. annual capital expenditures?

The current annual CAPEX of VIR is $7.30M

What is the all time high annual CAPEX for Vir Biotechnology, Inc.?

Vir Biotechnology, Inc. all-time high annual capital expenditures is $68.01M

What is Vir Biotechnology, Inc. annual CAPEX year-on-year change?

Over the past year, VIR annual capital expenditures has changed by -$14.27M (-66.16%)

What is Vir Biotechnology, Inc. quarterly capital expenditures?

The current quarterly CAPEX of VIR is $2.54M

What is the all time high quarterly CAPEX for Vir Biotechnology, Inc.?

Vir Biotechnology, Inc. all-time high quarterly capital expenditures is $20.60M

What is Vir Biotechnology, Inc. quarterly CAPEX year-on-year change?

Over the past year, VIR quarterly capital expenditures has changed by +$1.87M (+281.08%)

What is Vir Biotechnology, Inc. TTM capital expenditures?

The current TTM CAPEX of VIR is $8.93M

What is the all time high TTM CAPEX for Vir Biotechnology, Inc.?

Vir Biotechnology, Inc. all-time high TTM capital expenditures is $68.50M

What is Vir Biotechnology, Inc. TTM CAPEX year-on-year change?

Over the past year, VIR TTM capital expenditures has changed by +$1.14M (+14.68%)
On this page